重症肺炎药物治疗的研究进展  

Research Progress of Drug Treatment of Severe Pneumonia

作　　者：常朝霞 牛毅[2] 

机构地区：[1]青海大学研究生院,青海 西宁 [2]青海大学附属医院重症医学科,青海 西宁

出　　处：《临床医学进展》2023年第6期9217-9222,共6页Advances in Clinical Medicine

摘　　要：重症肺炎是一种呼吸系统急危重疾病,发展迅速、病情凶险,可导致严重的并发症。在其发病初期,正确使用药物,能够及时挽救患者生命。关于重症肺炎研究是广泛的,在宿主免疫反应、疾病严重程度的评估、微生物原因、多药耐药病原体的危险因素、诊断测试和治疗选择方面吸引了不同的观点。本文就重症肺炎的药物治疗研究进展综述如下。Severe pneumonia is an acute and critical disease of the respiratory system, which develops rapidly and is dangerous, and can lead to serious complications. In the early stage of its onset, the correct use of drugs can save the patient’s life in time. Research on severe pneumonia is extensive, attract-ing diverse perspectives on host immune responses, assessment of disease severity, microbial causes, risk factors for multidrug-resistant pathogens, diagnostic tests, and treatment options. In this article, the research progress of drug therapy for severe pneumonia is summarized as follows.

关 键 词：重症肺炎 药物治疗 抗生素 激素 免疫球蛋白 抗病毒 

分 类 号：R47[医药卫生—护理学]